GlassScriptPhysician profile
Todd R Jorgensen
NPI 1841265741
$989.70
in general payments reported to CMS, 2019-2025
18 companies · $221 in 2025
The $221 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $84.38 · 2020: $15.90 · 2021: $11.91 · 2022: $213 · 2023: $172 · 2024: $272 · 2025: $221.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $665.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $664.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tanabe Pharma America, INC. | $169.97 | 2020-2025 | Radicava |
| Grifols USA, LLC | $156.39 | 2023-2025 | Gamunex-C |
| Ipsen Biopharmaceuticals, INC | $152.07 | 2023-2025 | Dysport |
| Merz Pharmaceuticals, LLC | $125.00 | 2022-2025 | Xeomin |
| Abbvie INC. | $54.33 | 2022 | |
| Boston Scientific Corporation | $49.87 | 2025 | Intracept, General - Pain Management |
| Pacira Pharmaceuticals Incorporated | $41.29 | 2023-2024 | Iovera, Zilretta |
| Spr Therapeutics, INC | $33.09 | 2024-2025 | Sprint Pns System |
| Pfizer INC. | $28.59 | 2019 | |
| Allergan, INC. | $28.48 | 2019 | |
| Globus Medical, INC. | $25.40 | 2025 | Senza |
| Genzyme Corporation | $23.39 | 2024 | |
| Si-Bone, INC. | $23.28 | 2022 | |
| Fidia Pharma USA INC. | $18.43 | 2022 | |
| Depuy Synthes Sales INC. | $18.06 | 2024 | Orthovisc, Monovisc |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $15.50 | 2019 | |
| Averitas Pharma INC. | $14.75 | 2024 | Qutenza |
| Arbor Pharmaceuticals, INC. | $11.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Jorgensen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.